This kit is suitable for in vitro qualitative detection of 14 types of human papilloma viruses (HPV) (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) specific nucleic acid fragments in female cervical exfoliated cells and HPV 16/18 typing, to help diagnose and treat HPV infections.
Cervical cancer is one of the most common malignant tumors of the female reproductive tract. Studies have shown that HPV persistent infections and multiple infections are one of the main causes of cervical cancer. Currently, the recognized effective treatments are still lack for cervical cancer caused by HPV, so early discovery and prevention of cervical infection caused by HPV is the key to preventing cervical cancer. It is of great significance to establish a simple, specific and rapid etiology diagnostic test for the clinical diagnosis and treatment of cervical cancer.
The detection of kit cannot be applied alone or prior to cervical cytology, and it is not recommended to use this kit alone for cervical cancer screening in any age group. This test cannot replace cervical cytology, nor can it be used alone as the basis for patient management. Since the kit has not undergone corresponding clinical trials, it should not be used for clinical purposes related to cervical cancer screening.